Immunotherapy in non-small cell lung cancer: current status, advances and challenges

被引：0
|
作者：
Tartarone, Alfredo [1 ]
Lerose, Rosa [2 ]
Tartarone, Marina [3 ]
机构：
[1] IRCCS CROB Referral Canc Ctr Basilicata, Dept Onco Hematol, Div Med Oncol, Via Padre Pio 1, I-85028 Rionero In Vulture, Potenza, Italy
[2] IRCCS CROB Referral Canc Ctr Basilicata, Hosp Pharm, Rionero In Vulture, Potenza, Italy
[3] Humanitas Univ, Milan, Italy
来源：
MINERVA RESPIRATORY MEDICINE | 2024年 / 63卷 / 03期
关键词：
Carcinoma; non-small-cell lung; Immunotherapy; Immune checkpoint inhibitors; NIVOLUMAB PLUS IPILIMUMAB; OPEN-LABEL; 1ST-LINE TREATMENT; BRAIN METASTASES; POOLED ANALYSIS; CHECKMATE; 9LA; PEMBROLIZUMAB; CHEMOTHERAPY; DOCETAXEL; PHASE-3;
D O I：
10.23736/S2784-8477.24.02108-9
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
In recent years, thanks to the advent of immunotherapy, the therapeutic landscape of non-oncogene-addicted non-small cell lung cancer (NSCLC) has undergone a complete revolution. So far, several monoclonal antibodies directed against PD-1, PD-L1, or CTLA-4, known as immune checkpoint inhibitors (ICIs), administered alone or in combination with other agents have shown efficacy in metastatic setting as well as, more recently, even in the early-stage. We reviewed the role of immunotherapy in NSCLC focusing the attention not only on the results of the main currently available clinical trials but also on novel combination strategies.
引用
下载
收藏
页码：110 / 120
页数：11
相关论文
共 50 条
  • [1] Current status of immunotherapy for non-small cell lung cancer
    Yang, Tao
    Xiong, Yilin
    Zeng, Yufei
    Wang, Yan
    Zeng, Jing
    Liu, Jie
    Xu, Shangfu
    Li, Li-Sheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Advances in Immunotherapy for Non-Small Cell Lung Cancer
    Reckamp, Karen L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (12) : 847 - 853
  • [3] Liquid biopsy on the horizon in immunotherapy of non-small cell lung cancer: current status, challenges, and perspectives
    Yang, Ying
    Liu, Hongyang
    Chen, Youming
    Xiao, Nan
    Zheng, Zhaoyang
    Liu, Hongchun
    Wan, Junhu
    CELL DEATH & DISEASE, 2023, 14 (03)
  • [4] Liquid biopsy on the horizon in immunotherapy of non-small cell lung cancer: current status, challenges, and perspectives
    Ying Yang
    Hongyang Liu
    Youming Chen
    Nan Xiao
    Zhaoyang Zheng
    Hongchun Liu
    Junhu Wan
    Cell Death & Disease, 14
  • [5] Non-small cell lung cancer organoids: Advances and challenges in current applications
    Maoqin Wu
    Yi Liao
    Liling Tang
    Chinese Journal of Cancer Research, 2024, 36 (05) : 455 - 473
  • [6] Diagnosis and treatment of non-small cell lung cancer: current advances and challenges
    Diebels, Ian
    Van Schil, Paul E. Y.
    JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 1753 - 1757
  • [7] New advances in immunotherapy for non-small cell lung cancer
    Qin, Haifeng
    Wang, Fang
    Liu, Hui
    Zeng, Zhen
    Wang, Shasha
    Pan, Xin
    Gao, Hongjun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2234 - 2245
  • [8] Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy
    Patel, Shetal A.
    Weiss, Jared
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 237 - +
  • [9] Immunotherapy in non-small cell lung cancer: advancements and challenges
    Zhou, Fei
    Zhou, Cai-Cun
    CHINESE MEDICAL JOURNAL, 2021, 134 (10) : 1135 - 1137
  • [10] Immunotherapy in Non-Small Cell Lung Cancer Treatment Current Status and the Role of Imaging
    Carter, Brett W.
    Halpenny, Darragh F.
    Ginsberg, Michelle S.
    Papadimitrakopoulou, Vassiliki A.
    de Groot, Patricia M.
    JOURNAL OF THORACIC IMAGING, 2017, 32 (05) : 300 - 312
12345